Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical Corp. (TSE:ENBI)
:ENBI
ENBI Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.45
Previous CloseN/A
Volume100.00
Average Volume (3M)15.79K
Market Cap
C$2.01M
Enterprise ValueC$1.85M
Total Cash (Recent Filing)C$344.03K
Total Debt (Recent Filing)C$23.15K
Price to Earnings (P/E)―
Beta2.16
Next Earnings
Apr 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding13,858,926
10 Day Avg. Volume7,736
30 Day Avg. Volume15,789
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)21.90
Price to Cash Flow (P/CF)-4.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Grants Incentive Stock Options to Directors
PremiumCompany Announcements
Entheon Biomedical Ends Acquisition Agreement with Mentis AI
PremiumCompany Announcements
Entheon Biomedical Secures $500,000 in Private Placement
PremiumCompany Announcements
Entheon Biomedical Announces New Private Placement FinancingPremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private Placement---
Options Prices
Currently, No data available
---
Ownership Overview
15.59% Insiders
―
Mutual Funds
― Other Institutional Investors
84.41% Public Companies and
Individual Investors
ENBI FAQ
What was Entheon Biomedical Corp.’s price range in the past 12 months?
Entheon Biomedical Corp. lowest stock price was C$0.07 and its highest was C$0.45 in the past 12 months.
What is Entheon Biomedical Corp.’s market cap?
Entheon Biomedical Corp.’s market cap is C$2.01M.
When is Entheon Biomedical Corp.’s upcoming earnings report date?
Entheon Biomedical Corp.’s upcoming earnings report date is Apr 25, 2025 which is in 24 days.
How were Entheon Biomedical Corp.’s earnings last quarter?
Entheon Biomedical Corp. released its earnings results on Mar 05, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
Is Entheon Biomedical Corp. overvalued?
According to Wall Street analysts Entheon Biomedical Corp.’s price is currently Overvalued.
Does Entheon Biomedical Corp. pay dividends?
Entheon Biomedical Corp. does not currently pay dividends.
What is Entheon Biomedical Corp.’s EPS estimate?
Entheon Biomedical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical Corp. have?
Entheon Biomedical Corp. has 13,858,926 shares outstanding.
What happened to Entheon Biomedical Corp.’s price movement after its last earnings report?
Entheon Biomedical Corp. reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Entheon Biomedical Corp.?
Currently, no hedge funds are holding shares in TSE:ENBI
---
Company Description
Entheon Biomedical Corp.
Entheon Biomedical (ENBI) is a biotechnology company focused on the research and development of psychedelic-based therapeutic solutions to treat addiction and other mental health disorders. Operating within the biopharmaceutical sector, Entheon is dedicated to advancing the scientific understanding and clinical application of psychedelic compounds, particularly DMT (N,N-Dimethyltryptamine), to address unmet medical needs.
---
Technical Analysis
---